Charles River Laboratories | CRL - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Agilent USD 3.64B 594M 2026-06
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 803M 100K 2026-06
Bruker USD 1.81B 151.8M 2026-06
Cardinal Health USD 7B 1.24B 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Cigna USD 29.09B 285M 2026-06
Concord Medical Services Hldg CNY 2.47B 197.85M 2025-12
CVS Health USD 59.45B 1.08B 2026-06
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2B 10M 2026-06
Elevance Health USD 30.67B 99M 2026-06
Humana USD 11.98B 295M 2026-06
Illumina USD 1.49B 1000K 2026-06
Incyte USD 28.42M 994K 2026-06
Intrexon USD 0 198.67M 2024-06
IQVIA Holdings USD 13.7B 284M 2026-06
Laboratory Of America USD 5.92B 23.3M 2026-06
Lakefront Biotherapeutics EUR 4.77M 78K 2026-06
Lonza CHF 3.88B 323M 2025-12
McKesson USD 8.43B 3.17B 2026-06
Merck EUR 11.21B 406M 2026-06
Mettler Toledo International USD 2.04B 116.92M 2026-06
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
Quest Diagnostics USD 5.63B 477M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06
United Therapeutics USD 100M 100M 2024-06
UnitedHealth USD 69.5B 1.94B 2026-06
Veradigm USD 200.4M 69K 2022-12
Waters USD 5.09B 129M 2026-06
West Pharmaceutical Services USD 202.9M 100K 2026-06